Matuzumab (EMD 72000) is a humanized anti-EGFR monoclonal antibody investigated for non-small cell lung cancer. It inhibits EGFR activation and downstream signaling pathways. Research applications include in vitro cell proliferation assays and in vivo xenograft models to study its antitumor effects.
Concentration:
4.63 mg/mL
Molecular Weight:
145.9 kDa
Purity:
99.35% (May vary between batches)
CAS Number:
[339186-68-4]
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted